Highlights

  • Developed an oral arsenic preparation to treat leukaemia, a first patented prescription drug developed entirely in Hong Kong
  • Identified and characterised cancer stem cells responsible for metastasis in colorectal cancer, and the development of liver cancer
  • Discovered a new mechanism causing Lynch Syndrome that has become a diagnostic test adopted worldwide
  • Established zebrafish as a model organism for acute myeloid leukaemia (AML) and identified novel therapeutic regimens for specific AML subtypes that improve patient outcomes
  • Hepatitis B virus infection and hepatocellular carcinoma: from diagnosis and treatment of chronic carrier status, mechanisms of hepatocellular carcinogenesis, to development of novel treatment modalities including live-donor liver transplantation
  • Groundbreaking and comprehensive genomic study of gastric and liver cancers


RGC Theme-based Research / Area of Excellence Scheme


RGC Research Impact Fund


State Key Laboratory


Other Strategic Project